J Cuzick

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

M. Dowsett, Torsten O. Nielsen, Roger A’Hern et al. · JNCI Journal of the National Cancer Institute · 2011 · 2K citations · Full text

Medicine, Cancer Biology, Oncology +8

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

M Baum, Aman U. Budzar, J Cuzick et al. · The Lancet · 2002 · 2K citations

Pharmacy, Oncology, Pharmacotherapy +13

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

J Cuzick, JF Forbes, Rob Edwards et al. · The Lancet · 2002 · 742 citations

Medicine, Preventive Medicine, Women's Health +1

Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies.

JN Ingle, Mitch Dowsett, J Cuzick et al. · Cancer Research · 2009 · 38 citations

Medicine, Endocrinology, Oncology +17

Risk of distant recurrence using oncotype DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.

Mitch Dowsett, J Cuzick, Craig Wales et al. · Cancer Research · 2009 · 35 citations

Medicine, Oncology, Pharmacology +17